Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.45 USD | -2.03% | +3.57% | -17.61% |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 71.11M |
---|---|---|---|---|---|
Net income 2024 * | -33M | Net income 2025 * | -45M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-2.54
x | P/E ratio 2025 * |
-2.3
x | Employees | 28 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 89.43% |
Latest transcript on Corvus Pharmaceuticals, Inc.
1 day | -2.03% | ||
1 week | +3.57% | ||
Current month | -18.54% | ||
1 month | -17.61% | ||
3 months | -29.27% | ||
6 months | +26.09% | ||
Current year | -17.61% |
Managers | Title | Age | Since |
---|---|---|---|
Richard Miller
CEO | Chief Executive Officer | 73 | 14-01-26 |
Leiv Lea
DFI | Director of Finance/CFO | 70 | 14-01-26 |
James Rosenbaum
CTO | Chief Tech/Sci/R&D Officer | - | 22-07-20 |
Members of the board | Title | Age | Since |
---|---|---|---|
Richard Miller
CEO | Chief Executive Officer | 73 | 14-01-26 |
Ian Clark
BRD | Director/Board Member | 62 | 17-01-02 |
Terry Gould
BRD | Director/Board Member | 67 | 14-10-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 1.45 | -2.03% | 124,494 |
24-04-25 | 1.48 | -1.99% | 66,282 |
24-04-24 | 1.51 | -1.31% | 90,571 |
24-04-23 | 1.53 | +6.25% | 137,350 |
24-04-22 | 1.44 | +2.86% | 130,642 |
Delayed Quote Nasdaq, April 26, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-17.61% | 71.11M | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- CRVS Stock